Cargando…

A Comparison of Short- and Long-Term Therapeutic Outcomes of Infliximab- versus Tacrolimus-Based Strategies for Steroid-Refractory Ulcerative Colitis

Background/Aims. Antitumor necrosis factor antibodies and calcineurin inhibitors have shown good therapeutic efficacy for steroid-refractory ulcerative colitis (UC). Although some studies have compared the efficacy of infliximab (IFX) and cyclosporin A, there are no published studies comparing IFX a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Endo, Katsuya, Onodera, Motoyuki, Shiga, Hisashi, Kuroha, Masatake, Kimura, Tomoya, Hiramoto, Keiichiro, Kakuta, Yoichi, Kinouchi, Yoshitaka, Shimosegawa, Tooru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4745932/ https://www.ncbi.nlm.nih.gov/pubmed/26904108 http://dx.doi.org/10.1155/2016/3162595

Ejemplares similares

Two Cases of Diffuse Duodenitis Associated with Ulcerative Colitis
por: Endo, Katsuya, et al.
Publicado: (2012)

Acute Onset Collagenous Colitis with Unique Endoscopic Findings
por: Moroi, Rintaro, et al.
Publicado: (2014)

Effective and less invasive diagnostic strategy for gastrointestinal GVHD
por: Endo, Katsuya, et al.
Publicado: (2018)

Long-term prognosis of Japanese patients with biologic-naïve Crohn’s disease treated with anti-tumor necrosis factor-α antibodies
por: Moroi, Rintaro, et al.
Publicado: (2019)

Serum C-reactive protein and albumin are useful biomarkers for tight control management of Crohn’s disease in Japan
por: Shiga, Hisashi, et al.
Publicado: (2020)

Allele-specific DNA methylation of disease susceptibility genes in Japanese patients with inflammatory bowel disease
por: Chiba, Hirofumi, et al.
Publicado: (2018)

Correction: Allele-specific DNA methylation of disease susceptibility genes in Japanese patients with inflammatory bowel disease
por: Chiba, Hirofumi, et al.
Publicado: (2019)

TL1A (TNFSF15) genotype affects the long‐term therapeutic outcomes of anti‐TNFα antibodies for Crohn's disease patients
por: Endo, Katsuya, et al.
Publicado: (2020)

Immunoglobulin subtype-coated bacteria are correlated with the disease activity of inflammatory bowel disease
por: Masu, Yutaro, et al.
Publicado: (2021)

Ileocecal ulcers accompanied by relapsing polychondritis: a case report
por: Kawakami, Yoko, et al.
Publicado: (2014)

Life-event stress induced by the Great East Japan Earthquake was associated with relapse in ulcerative colitis but not Crohn's disease: a retrospective cohort study
por: Shiga, Hisashi, et al.
Publicado: (2013)

The clinical practice of ulcerative colitis in elderly patients: An investigation using a nationwide database in Japan
por: Moroi, Rintaro, et al.
Publicado: (2021)

Pharmacogenetics of thiopurines for inflammatory bowel disease in East Asia: prospects for clinical application of NUDT15 genotyping
por: Kakuta, Yoichi, et al.
Publicado: (2017)

Endoscopic radial incision and cutting for Crohn’s Disease-associated intestinal stricture: a pilot study
por: Moroi, Rintaro, et al.
Publicado: (2020)

A pilot study investigating the safety and feasibility of endoscopic dilation using a radial incision and cutting technique for benign strictures of the small intestine: a study protocol
por: Moroi, Rintaro, et al.
Publicado: (2022)

Analysis of the disease activity of ulcerative colitis with and without concomitant primary sclerosing cholangitis: An investigation using a nationwide database in Japan
por: Yano, Kota, et al.
Publicado: (2021)

EP1276: USTEKINUMAB HAS COMPARABLE LONG-TERM EFFECTIVENESS AS ANTI-TNF AGENTS IN BIOLOGIC-NAÏVE PATIENTS WITH CROHN'S DISEASE
por: Shiga, Hisashi, et al.
Publicado: (2022)

Validity of Diagnostic Algorithms for Inflammatory Bowel Disease in Japanese Hospital Claims Data
por: Takahashi, Sayumi, et al.
Publicado: (2022)

Liquid Biopsy for Colorectal Adenoma: Is the Exosomal miRNA Derived From Organoid a Potential Diagnostic Biomarker?
por: Handa, Tomoyuki, et al.
Publicado: (2021)

Long‐term effectiveness of ustekinumab comparable to antitumor necrosis factor agents in patients with Crohn's disease
por: Shiga, Hisashi, et al.
Publicado: (2022)

Periostin attenuates tumor growth by inducing apoptosis in colitis-related colorectal cancer
por: Shimoyama, Yusuke, et al.
Publicado: (2018)

Long‐term prognosis and clinical practice for new‐onset ulcerative colitis in the era of biologics: A Japanese retrospective study
por: Moroi, Rintaro, et al.
Publicado: (2023)

Repertoire analysis of memory T‐cell receptors in Japanese patients with inflammatory bowel disease
por: Kakuta, Yoichi, et al.
Publicado: (2020)

Response to COVID‐19 vaccine is reduced in patients with inflammatory bowel disease, but improved with additional dose
por: Shiga, Hisashi, et al.
Publicado: (2022)

Pooled analysis of the comparative efficacy between tacrolimus and infliximab for ulcerative colitis
por: Liu, Yi-Juan, et al.
Publicado: (2018)

Efficacy of infliximab, cyclosporine and tacrolimus on ulcerative colitis: A meta-analysis
por: Jia, Xuemei, et al.
Publicado: (2020)

The Impact of Concomitant Ulcerative Colitis on the Clinical Course in Patients with Primary Sclerosing Cholangitis: An Investigation Using a Nationwide Database in Japan
por: Moroi, Rintaro, et al.
Publicado: (2023)

Depression is associated with increased disease activity in patients with ulcerative colitis: A propensity score‐matched analysis using a nationwide database in Japan
por: Oyama, Hideaki, et al.
Publicado: (2022)

Network meta-analysis and cost-effectiveness analysis of infliximab, cyclosporine and tacrolimus for ulcerative colitis
por: Wang, Xueqi, et al.
Publicado: (2022)

Infliximab in ulcerative colitis
por: Levin, Avi, et al.
Publicado: (2008)

Three‐dimensional Reconstruction and Fractal Geometric Analysis of Serrated Adenoma
por: Iwabuchi, Masahiro, et al.
Publicado: (2002)

An Integrated Genomic and Transcriptomic Analysis Reveals Candidates of Susceptibility Genes for Crohn’s Disease in Japanese Populations
por: Kakuta, Yoichi, et al.
Publicado: (2020)

Ipilimumab and Nivolumab induced steroid-refractory colitis treated with infliximab: A case report
por: Nassri, Ammar B, et al.
Publicado: (2019)

Tacrolimus or infliximab for severe ulcerative colitis: short-term and long-term data from a retrospective observational study
por: Minami, Naoki, et al.
Publicado: (2015)

Tacrolimus for the Treatment of Ulcerative Colitis
por: Matsuoka, Katsuyoshi, et al.
Publicado: (2015)

The Effectiveness of Self-Expandable Metallic Stent Insertion in Treating Right-Sided Colonic Obstruction: A Comparison between SEMS and Decompression Tube Placement and an Investigation of the Safety and Difficulties of SEMS Insertion in Right Colons
por: Moroi, Rintaro, et al.
Publicado: (2014)

Comparative efficacy of antitumor necrosis factor agents and tacrolimus in naïve steroid-refractory ulcerative colitis patients
por: Kitayama, Moto, et al.
Publicado: (2020)

NUDT15 codon 139 is the best pharmacogenetic marker for predicting thiopurine-induced severe adverse events in Japanese patients with inflammatory bowel disease: a multicenter study
por: Kakuta, Yoichi, et al.
Publicado: (2018)

Infliximab versus cyclosporine for severe ulcerative colitis refractory to steroids: A protocol for systematic review and meta-analysis
por: Wu, Dongjie, et al.
Publicado: (2018)

Severity of acute pancreatitis in patients with inflammatory bowel disease in the era of biologics: A propensity‐score‐matched analysis using a nationwide database in Japan
por: Moroi, Rintaro, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3t7f73llrjmitl1u4vi4vilb7e